Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Literature DB >> 17665195

Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Giovanni Lucignani¹.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2007 PMID： 17665195 DOI： 10.1007/s00259-007-0509-z

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

19 in total

1. Procedure guideline for therapy of thyroid disease with (131)iodine.

Authors: Donald A Meier; David R Brill; David V Becker; Susan E M Clarke; Edward B Silberstein; Henry D Royal; Helena R Balon
Journal: J Nucl Med Date: 2002-06 Impact factor: 10.057

2. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.

Authors: Cristina Canzi; Felicia Zito; Franco Voltini; Eugenio Reschini; Paolo Gerundini
Journal: Med Phys Date: 2006-08 Impact factor: 4.071

3. Cardiovascular and cancer mortality after radioiodine treatment of hyperthyroidism.

Authors: Mark Vanderpump
Journal: J Clin Endocrinol Metab Date: 2007-06 Impact factor: 5.958

4. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.

Authors: Saara Metso; Pia Jaatinen; Heini Huhtala; Anssi Auvinen; Heikki Oksala; Jorma Salmi
Journal: J Clin Endocrinol Metab Date: 2007-03-20 Impact factor: 5.958

Review 5. Patient misconceptions and ethical challenges in radioactive iodine scanning and therapy.

Authors: M Sara Rosenthal
Journal: J Nucl Med Technol Date: 2006-09

6. Increased cancer incidence after radioiodine treatment for hyperthyroidism.

Authors: Saara Metso; Anssi Auvinen; Heini Huhtala; Jorma Salmi; Heikki Oksala; Pia Jaatinen
Journal: Cancer Date: 2007-05-15 Impact factor: 6.860

7. Radioiodine treatment for benign thyroid diseases.

Authors: Anthony P Weetman
Journal: Clin Endocrinol (Oxf) Date: 2007-04-25 Impact factor: 3.478

8. The European Directive on health protection of individuals against the dangers of ionising radiation in relation to medical exposures (97/43/EURATOM).

Authors: D Teunen
Journal: J Radiol Prot Date: 1998-06 Impact factor: 1.394

9. Quantitative analysis of the factors responsible for over or under dose of 131 I therapy patients of hyperthyroidism.

Authors: Wazir Muhammad; Shafqat Faaruq; Amjad Hussain; M Basim Kakakhail; Shahab Fatmi
Journal: Radiat Prot Dosimetry Date: 2007-05-27 Impact factor: 0.972

10. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

Authors: James C Sisson; Anca M Avram; Domenico Rubello; Milton D Gross
Journal: Eur J Nucl Med Mol Imaging Date: 2007-04-25 Impact factor: 10.057

7 in total

1. Comment on long-term risk in radioiodine treatment of hyperthyroidism.

Authors: Agata Baldys-Waligorska; Alicja Hubalewska-Dydejczyk
Journal: Eur J Nucl Med Mol Imaging Date: 2008-09 Impact factor: 9.236

2. EANM procedure guidelines for therapy of benign thyroid disease.

Authors: Marcel P M Stokkel; Daria Handkiewicz Junak; Michael Lassmann; Markus Dietlein; Markus Luster
Journal: Eur J Nucl Med Mol Imaging Date: 2010-07-13 Impact factor: 9.236

3. Papillary thyroid carcinoma in cervical lymph nodes with vanished thyroid gland after ablation of Graves' disease by radioactive iodine.

Authors: O Hamdy; S Raafat; G A Saleh; K Atallah; Mahmoud M Saleh; A M Shebl; M A Hegazy
Journal: Ann R Coll Surg Engl Date: 2019-03-11 Impact factor: 1.891